On January 17, 2022 Bio-Techne Corporation (NASDAQ: TECH) reported that management will host a conference call and webcast on Tuesday, February 1, 2022, at 8:00 a.m. CST to review second quarter fiscal 2022 financial results (Press release, Bio-Techne, JAN 17, 2022, https://investors.bio-techne.com/news/detail/286/bio-techne-to-host-conference-call-on-february-1-2022-to-announce-second-quarter-2022-financial-results [SID1234605507]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Access to the discussion may be obtained as follows:
Time:
8:00 a.m. CST
Date:
February 1, 2022
Dial-in:
1-877-407-9208 or 1-201-493-6784 (for international callers)
Conference ID:
13726340
Webcast:
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13726340.
The replay will be available from 11:00 a.m. CST on Tuesday, February 1, 2022, until 11:00 p.m. CST on Tuesday, March 1, 2022.